MCT’s collaboration with Onxeo on HCC Phase III study in Middle East

/ News /

Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon, Egypt and Saudi Arabia). More information in Onxeo press release: 150326EN_Livatag

Related Posts

MCT new Headquarter in Tunis

News /

MCT inaugurates on 21/01/13 it new Headquarter in Tunisia. After 15 months in El Aouina area, MCT is back in Les berges du lac. Former…

Saudi Arabia – SFDA accreditation

News /

Following inspection, MCT local team obtained SFDA accreditation on 06/04/14. This certification successfully concludes a process initiated by SFDA for CROs. Saudi local team has…